Abstract: The effect of selenium (Se) on natural killer (NK) and lymphokine-activated killer (LAK) cell activities and proliferative responses of human lymphocytes was studied in vitro. Direct addition of Se at 1.0 #g/ml final concentration to the mixture of target and effector cells during a 4 h cytotoxicity assay significantly suppressed the NK activity of normal lymphocytes. When lymphocytes were preincubated with Se at concentrations as low as 0.2 #g/ml for a period of 48 h, a significant inhibitory effect on NK activity was observed. In the LAK cell assay, direct addition of Se at concentrations of 0.2 1.0 t~g/ml to a mixture of target and effector cells did not show any effects on LAK cell activity, whereas LAK cells generated in the presence of Se at 0.8 #g/ml showed significant inhibition of their functions. Lymphocyte proliferative responses to T cell mitogens such as phytohemagglutinin (PHA) and concanavalin A (Con A) were also significantly suppressed by direct addition of Se at 0.5 1.0 l~g/ml. The inhibitory effect of Se was not due to nonspecific toxicity of effector cells as demonstrated by viability nor was the effect directed against target cells. These studies suggest that although Se is an essential micronutrient for various immune mechanisms, an excess of Se may have a deleterious effect on certain immunological functions. As these activities are considered to be important defense mechanisms against tumors and virus infections, a nutritional imbalance of Se could result in an increased risk of these disorders.
Introduction
Nutrition plays an important role in host responses to various infections and carcinogens (Yang et al., 1987; Reddy et al., 1980; Byers et al., 1984) . Several studies have indicated that immunodeficiency or defective immunoregulation, such as reduced natural killer (NK) and lymphokine-activated killer (LAK) cells, increased suppressor or decreased helper cell activities, or altered T and B cell responses, is associated with cancer (Herberman et al., 1978; RosenCorrespondence." Abbreviations." Se, selenium; LAK, lymphokine-activated killer cells; N K, natural killer cells; PHA, phytohemagglutinin; Con A, concanavalin A; PBMC, peripheral blood mononuclear cells; PBL, peripheral blood lymphocytes. berg et al., 1986; Whong-Peng et al., 1978) . Like zinc (Zn) and copper (Cu), selenium (Se) is an accepted micronutrient with established RDAs (Mertz et al., 1986) . Previous studies have shown that Se deficiency resulted in down-regulation of various immune functions such as lymphocyte proliferative response to various mitogens (Eskew et al., 1985; Parnharn et al., 1983; Sheffy et al., 1979) , polyclonal B cell activation (Chandra et al., 1982) and granulocyte (Urban et al., 1986) and cytotoxic cell (Kiremidjian-Schumacher et al., 1987; Petrie et al., 1989a) activities, and supplementation of Se was associated with restoration of certain depressed immune functions (Petrie et al., 1989b; Arvilommi et al., 1983; Spallholz et al., 1981; Koller et al., 1986) . A recent study suggests that Se can effectively inhibit mixed lymphocyte culture reactions and in vitro 0162-3109/90/$03.50 c~') 1990 Elsevier Science Publishers B.V. (Biomedical Division) lymphocyte responses to tetanus toxoid (Petrie et al., 1986) . The effect of Se imbalance on immune functions has not been extensively examined, especially its effects on the cytotoxic activities of NK and LAK cells. The present study examines the effects of Se (as sodium selenite) on NK, LAK and lymphocyte proliferative responses.
Materials and Methods

Media
'Complete medium' consisted of RPMI 1640 (GIB-CO, Grand Island, NY), with 25 mM HEPES buffer, 80 /~g/ml gentamicin (Schering Corp., Kenilworth, N J), 300 #g of fresh glutamine/ml, and 10% heat-inactivated fetal calf serum (v/v).
Isolation of lymphocytes
Peripheral blood mononuclear cells (PBMC) were isolated from heparinized (20 U/ml) venous blood from healthy normal donors using a modified method of Boyum (Boyum, 1968) . Blood was diluted with an equal volume of normal saline and centrifuged at 400 × g for 30 rain at 18°C. The mononuclear cell band was harvested, washed three times with saline, and resuspended in complete medium as described (Nair et al., 1988) .
Depletion of adherent cells
PBMC were suspended in complete medium and depleted of adherent cells by passage through a 7 ml column of Sephadex G-10 beads (Pharmacia Fine Chemicals, Piscataway, N J) and equilibrated in complete medium as previously described (Nair et al., 1988) . After 45 min of incubation at 37°C, nonadherent peripheral blood lymphocytes (PBL) were eluted with 1 bed volume of medium at 37°C. Cell recovery was > 70% of the total input, and monocyte contamination, as indicated by nonspecific esterase staining, was < 2%.
Assays Jor NK and LAK cell activities
LAK and NK cell activities were determined in a direct SlCr-release assay as described previously (Nair et al., , 1988 . The human myeloid cell line, K562, was used as target for NK cells because it is highly susceptible to NK activity (West et al., 1977) . For the LAK cell assay we chose as target a human B cell leukemia line, SB, because of its resistance to NK activity in a 4 h assay (Korea et al., 1978) . Briefly, varying concentrations of viable effector cells in complete medium were added to triplicate cultures of SlCr-labeled target cells in 0.2 ml volumes in V-bottom microtitration plates (Dynatech Labs, Alexandria, VA). After centrifugation at 40 x g for 2 min, the cells were incubated at 37°C in a humidified atmosphere of 5% CO2 in air for 4 h. Percent cytotoxicity was calculated as follows: % Cytotoxicity = experimental release -spontaneous release × 100 total release spontaneous release where total release represents counts obtained in an aliquot of 2 x 10 ¢ lysed target cells, and spontaneous release represents counts obtained from control wells containing only 2 × 10 ~ target cells and media during 4 h incubation. The spontaneous release from target cells was always less than 5% of the total release.
Generation o[" LAK cells
Commercially available recombinant IL2 alpha (Collaborative Research, Inc., Bedford, MA) was diluted in complete medium and stored at -70°C before use. IL2 concentrations of 5 10 U/ml in complete medium were used to generate LAK cells. PBL were activated to generate LAK cells by incubation for 4 days in LAK medium containing Se at concentrations ranging from 0.01 to 1 /,g/ml in upright 25 cm 2 flasks at a density of l x 10 6 cells/ ml at 37°C in a 5% CO2/95% air atmosphere as described (Nair et al., 1988) .
LymphocTte prol(/bration assay
This assay was performed as described (Nair et al., 1988) . Briefly, 2 x 105 PBMC were cultured in complete medium containing 10% fetal calf serum in sterile U-bottom microtitration plates (Dynatech, Alexandria, VA). Specific cultures received Se at concentrations of 0.2-1 /~g/ml. Lymphocyte activators such as PHA (2.5, 5 and 10/zg/ml) and Con A (1, 2.5 and 5 yg/ml) were added to Se-containing cultures and incubated for 72 h at 37°C in a 5% CO2/air incubator. Control cultures containing varying concentrations of Se or PHA alone were examined concomitantly. One ttCi of [3H]thymidine (1 Ci = 37 GBq) was added to each well during the last 24 h of incubation. The cultures were collected by an automated cell harvester and incorporation of [3H]thymidine into lymphocyte DNA was determined with a Beckman Model LS700 scintillation counter. Results are expressed as cpm per 2 x 10 s cells.
Statistical analysis
The significance of differences between control and experimental values was determined by a paired Student's 't' test.
Results
Effect of selenium ol7 NK and LAK cell activities of lymphocytes
Data presented in Table I to generate LAK cells demonstrated 100% viability at the end of 96 h of culture. Se at all tested concentrations produced levels of viability similar to those of control cultures. This demonstrates that Se at a concentration of up to 1 /g/ml is not toxic to the cells. Fig. 1 shows the effect of Se on NK activity when added directly to the target-effector cell mixture. Cytotoxicity was dependent upon the number of el- lector cells used, and the inhibitory effect of Se occurred at all effector-to-target (E:T) cell ratios. Se at lower concentrations (0.5 and 0.8 #g/ml) did not produce significant inhibitory effects on NK activity; however, significant suppression of NK activity was observed at 1/~g/ml (p < 0.005, p < 0.02 and p < 0.02 respectively at 25:1, 10:1 and 5:1 E:T cell ratios). The data in Fig. 2 demonstrate the effect of preculture oflymphocytes with Se for 48 h on their NK activity. A prior kinetic analysis (data not presented) showed that a minimum incubation period of 48 h was necessary for Se to effect significant inhibition of NK activity against K562 target cells. Se at 0.2 /~g/ml produced significant suppression of NK activity at all E:T cell ratios examined with resultant cytotoxicities of 65% (p < 0.01), 46% (p < 0.002) and 20% (p < 0.003) at E:T ratios of 50:1, 25:1 and 10:1 respectively; p values are relative to differences between control cultures without added Se. This inhibition was more pronounced at higher Se concentrations. For example, Se at 0.5 #g/ml produced 41% (p < 0.0), 24% (p < 0.001) and 8% (p < 0.001) cytotoxicity compared to 70%, 60% and 31% cytotoxicity produced by control cultures respectively at 50:1, 25:1 and 10:1 E:T cell ratios. Se at 1/2g/ml produced very significant suppression ofcytotoxicity, which was negligible at this concentration. Experiments were undertaken to investigate whether Se directly affects the activity and generation of LAK cells. Direct addition of Se at concentrations ranging from 0.2 to 1.0/2g/ml to a mixture of effector and target cells did not affect the lyric activity of LAK cells during a 4 h assay period (data not presented). Fig. 3 shows the cytotoxic activity of LAK cells generated for 96 h in the presence of different concentrations of Se against NK-nonsensitire SB target cells. Se at 0.8/~g/ml significantly inhibited LAK cell induction, yielding cytotoxicities of 65% (p < 0.01), 45% (p < 0.03) and 8% (p < 0.03) compared to 86%, 67% and 17% cytotoxicities manifested by control cultures respectively at 10:1, 5:1 and 1:1 E:T cell ratios. Se at l gg/ml demonstrated 66% (p < 0.01), 38% (p < 0.03) and 8% (p < 0.03) cytotoxicity versus cytotoxicities of 86%, 67% and 17% produced by control cultures at 10:1, 5:1 and l:1 E:T cell ratios respectively.
80-
Effect of Se on lymphocyte proliferative responses to mitogens
Previous work by others suggested that Se deficiency impairs lymphocyte proliferative responses to various mitogens (Eskew et al., 1985; Parnharn et al., 1983; Shefl'y et al., 1979) and polyclonal B cell activation (Chandra et al., 1982) . Thus we investigated the effects of excess Se on lymphocyte prolif- Fig. 4 demonstrate that PHA at 5 and 2.5 #g/ml produced significant proliferative responses (104,176 cpm and 70,048 cpm respectively) which were significantly suppressed by Se in a dose-dependent manner. At a concentration of 0.6/ag/ml, Se yielded reduced counts of 37,527 cpm (p < 0.01) and 10,481 cpm (p < 0.004) respectively at 5.0 and 2.5/~g/ml of PHA. At 0.8 ~g Se/ml counts were further reduced to 23,353 cpm (p < 0.001) and 6,606 cpm (p < 0.007) at 5.0 and 2.5 #g/ml of PHA respectively. A Se concentration of 1.0/ag/ml virtually completely inhibited PHA stimulated mitogenesis.
As shown in Fig. 5 , Se produced a similar dosedependent inhibition of Con A-induced proliferation. Suppression of responses to 5.0/~g/ml of Con A was significant at Se concentrations of 0.6 (p < 0.001), 0.8 (p < 0.006) and 1 (p < 0.007)/~g/ml. lation of several lymphocyte activities (Herberman et al., 1978; Rosenberg et al., 1986; Whong-Peng et al., 1978; Nair et al., , 1988 . Numerous epidemiological and experimental investigations suggest that Se has an anticarcinogenic effect (Schrauzer et al., 1977; Reddy et al., 1988; Uark 1985; Kobayashi et al., 1986; Willett et al., 1983; Thomson et al., 1984) . By contrast, it has also been shown that rats fed Se (4 ppm) during the post-initiation phase of carcinogenesis demonstrated enhanced development of colon cancer (Jacobs et al., 1981) . Reddy et al. (1988) observed an increased incidence of small intestinal tumors induced by carcinogen in rats fed an excess of Se, but Se deficiency inhibited colon tumorigenesis. Various investigators have noted that Se deficiency can result in impaired mitogenic responses of lymphocytes (Eskew et al., 1985; Sheffy et al., 1979) , decreased numbers and function of neutrophils and macrophages (Urban et al., 1986; Gyang et al., 1984; Boyne et al., 1979; Serfass et al., 1976; Talcott et al., 1984; Willett et al., 1988; Oldfield 1987) , and diminished antibody-producing cells (Chandra et al., 1982) . Talcott et al. (1984) reported that NK activity was stimulated slightly in female Sprague-Dawley rats given 2 ppm of Se. Ip and Ip (1981) found no alterations of in vitro immune functions such as mitogen stimulation or natural killer cell activities of lymphocytes from rats fed supra-nutritional levels of Se. Koller et al. (1986) showed that Se administered to rats in lower doses (0.5 2.0 ppm) significantly enhanced splenic NK activity, while no change was observed at higher concentrations of Se. Further, rats fed lower as well as higher Se levels manifested suppressed delayed hypersensitivity responses, while antibody synthesis was inhibited only at the highest Se levels. This suggests that Se can exert both stimulatory and inhibitory effects at various concentrations. Thus this dichotomy of effects of Se on various immune responses and tumorigenesis is not clearly understood and has been the subject of various reviews (Willett et al., 1988; Oldfield 1987) . The immunological alterations observed in these studies may be due to selective depletion or homing of certain lymphocyte subpopulations to various lymphoid organs depending upon Se deficiency or excess. Alternatively Se may directly affect lymphocyte functions or modulate them by selective activation or inhibition of various immunoregulatory cell subpopulations. Current investigations may resolve these questions. Se levels in various tissues vary considerably, with hair having the highest levels. A blood level of 3.2 #g/ml and a urine level of 2.68/~g/ml have been noted in chronic selenosis (Levander, 1985) . We report herein that Se, at lower concentrations than reported in selenosis (e.g. 0.5 1 #g/ml), significantly suppresses NK and LAK cell activities and the proliferative responses of normal lymphocytes. The reduced NK and LAK cell activities observed in Sesupplemented media were not due to direct toxicity of effector cells, because lymphocytes cultured in Se-supplemented media showed viability similar to control cultures without added Se. Further, equal numbers of viable effector cells were consistently used for control and Se-supplemented cultures for all assays. Experiments were also undertaken to examine whether inhibition of cytotoxicity was due to increased resistance of target cells to lysis after treatment with Se. Target cells were labeled with 51Cr, preincubated with Se, washed and used in NK cell assays. The results demonstrated that preincubation of targets with Se did not affect their sensitivity to lysis by effector cells (data not presented). In assays where effector cells were precultured in Se-containing medium, Se was removed after washing and the washed effector cells were then mixed with target cells, thus minimizing the carryover of Se to the mixture. These studies suggest that the effect of Se appears to be directly or indirectly on effector cells and not on target cells.
The exact mechanisms by which NK or LAK cell functions are affected in vitro by excess Se are not understood. Several explanations may underlie this suppression, including: (1) induction of cells capable of inhibiting NK/LAK cell functions; (2) decreased ability to recruit NK/LAK cells from precursors; (3) reduced production of NK/LAKcell-stimulating lymphokines (e.g., interferon/interleukin 2); (4) decreased production of cytotoxic factor; (5) failure of helper cell activation; (6) blocking of NK/LAK cell receptors, thus minimizing target binding; and/or (7) altered levels of reactive oxygen metabolites such as hydrogen peroxide, hydroxyl radical, or other oxygen intermediates which are believed to be involved in mediating cytotoxic reactions (Nathan, 1982) . These possibilities remain to be investigated. Thus, excess levels of Se as reported herein interfere with the cytotoxic functions of NK and LAK cells. To achieve an effective antitumor response in adoptive immunotherapy against malignancy, using IL2 or LAK cells, special consideration should be given to the blood Se levels of these patients.
